SCHEMBL574996

SCHEMBL574996

COC(=O)c1ccc(C23CC4CC(CC(C4)C2)C3)c(OC(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
CNR2 P34972 2/20 0.46
PKM P14618 1/20 0.46
EPHX2 P34913 2/20 0.43
RARA P10276 3/20 0.43
RARB P10826 3/20 0.43
RARG P13631 3/20 0.43
MEN1 O00255 1/20 0.43
NR1I2 O75469 1/20 0.43
LMNA P02545 1/20 0.43
PGR P06401 1/20 0.43
HSPD1 P10809 1/20 0.43
GOT1 P17174 1/20 0.43
GLRA1 P23415 1/20 0.43
BLM P54132 1/20 0.43
HSPE1 P61604 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HIF1A Q16665 8/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL566878 0.87 CNR2 (0.53) MAPTNPSR1CNR2PKMEPHX2
SCHEMBL566894 0.80 CA12 (0.53) MAPTNPSR1EPHX2RARARARB
SCHEMBL566278 0.79 RARA (0.62) MAPTNPSR1CNR2PKMEPHX2
SCHEMBL9126612 0.78 FAAH (0.49) MAPTNPSR1CNR2MEN1LMNA
SCHEMBL5888301 0.78 RARB (0.57) MAPTNPSR1EPHX2RARARARB
SCHEMBL7691706 0.77 RARA (0.51) CNR2PKMEPHX2RARARARB
SCHEMBL7689447 0.77 RARB (0.59) MAPTCNR2PKMRARARARB
SCHEMBL9123991 0.75 HIF1A (0.47) MAPTNPSR1EPHX2RARARARB
SCHEMBL565245 0.75 HDAC11 (0.43) RARARARBRARGMEN1NR1I2
SCHEMBL566311 0.75 CNR1 (0.42) CNR2RARARARBRARGMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181182-B2 S1P receptors modulators AKAAL PHARMA PTY LTD (AU) 2015-11-10 US disclosed
US-20120034270-A1 S1P Receptors Modulators AKAAL PHARMA PTY LTD (AU) 2012-02-09 US disclosed
EP-2344446-A1 S1P RECEPTORS MODULATORS Akaal Pharma Pty Ltd (AU) 2011-07-20 EP disclosed
WO-2010042998-A1 S1P RECEPTORS MODULATORS AKAAL PHARMA PTY LTD (AU) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120034270-A1 S1P Receptors Modulators S1PR1, S1PR5, S1PR3 MAPT 4146/4885NPSR1 152/4885CNR2 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.